Winship treats first lung cancer patient with T-cell receptor

Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial - The Lancet Oncology

Winship Magazine - Spring 2022 by EmoryWeb - Issuu

Articles and Media Releases - Archive

Cancers, Free Full-Text

Frontiers Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects

Spectacular Progress in Lung Cancer Care

Emory's Winship Joins AccessHope as Collaboration Partner

Letter from Jon Lewin

Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo - ScienceDirect